Immupharma (IMM) Share Price

Health Care Sector

  1. Home
    2. /
  2. Company
    3. /
  3. Immupharma

NOTE: This is based on 9 open tips for Immupharma (IMM)


Immupharma (IMM)
Latest Quote Price

2.28p

Immupharma (IMM)
Price Change (%)

-4.96%


Latest Bid : 2.27p Latest Ask : 2.56p
High Today : 2.56p Low Today : 2.27p
This Years High : 5.90p This Years Low : 1.09p
Volume : 1,051,850 MKT Cap : £9.48M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Immupharma (IMM) Overview

ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor™ is the company's most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.

Immupharma (IMM) Latest Tips

Type Tipster SectorScore Start date Performance
Avoid Steve Moore Premium Only 2025-02-13 16:05:00 13/02/2025 40.47%
Avoid Steve Moore Premium Only 2025-01-09 15:35:00 09/01/2025 32.94%
Buy Northland Capital Premium Only 2018-04-17 16:35:00 17/04/2018 -60.41%
Risky Buy Paul Summers Premium Only 2018-03-01 09:50:00 01/03/2018 -92.31%
Buy FinnCap Premium Only 2017-12-21 11:30:00 21/12/2017 -91.87%

Premium Content

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Immupharma (IMM) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 2.27p Latest Ask : 2.56p
High Today : 2.56p Low Today : 2.27p
This Years High : 5.90p This Years Low : 1.09p
Volume : 1,051,850 MKT Cap : £9.48M

Immupharma Overview

ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor™ is the company's most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Immupharma Tips

Type Tipster SectorScore Start date Performance
Avoid Steve Moore Premium Only 2025-02-13 16:05:00 13/02/2025 40.47%
Avoid Steve Moore Premium Only 2025-01-09 15:35:00 09/01/2025 32.94%
Buy Northland Capital Premium Only 2018-04-17 16:35:00 17/04/2018 -60.41%
Risky Buy Paul Summers Premium Only 2018-03-01 09:50:00 01/03/2018 -92.31%
Buy FinnCap Premium Only 2017-12-21 11:30:00 21/12/2017 -91.87%